Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to provide similar guidance to the temporary clinical authorisation granted by the Medicine and Healthcare Products Regulatory Agency (MHRA) to the Pfizer/BioNtech vaccine on 2 December 2020, to the MHRA in regards to the fast-tracking of nasal covid-19 vaccines; and if he will make a statement.

COVID-19 vaccines which can be administered nasally are currently in early clinical trials. Any route to approval of such treatments will be subject to the developer seeking regulatory approval from the United Kingdom’s independent medicines regulator, the Medicines and Healthcare products Regulatory Agency.